corporate_fare

Exciva GmbH

Address
Hauptstrasse 25, Altstadt

Sponsor Overview

assignment
1
sponsored trial
science
0
molecules
location_city
38
research centres
public
6
countries
person_search
37
investigators

Specializations

Alzheimer's disease dementia

Exciva GmbH focuses on neuropsychiatric symptoms associated with Alzheimer's disease dementia, with particular attention to agitation and related behavioral disturbances.

  • Agitation in Alzheimer's disease dementia
  • Behavioral and psychological symptoms of dementia
  • Neurocognitive disorders

The sponsor's research activity is centered on treatments intended to address symptom burden in people living with Alzheimer's disease, with clinical interest in improving control of agitation.

Neuropsychiatry

The clinical research portfolio includes neuropsychiatric symptom management, especially conditions where agitation affects daily functioning and care needs in dementia.

  • Symptom control
  • Behavioral disturbance
  • Psychiatric manifestations of dementia

This area reflects a therapeutic interest in the intersection of neurology and psychiatry within age-related cognitive disorders.

Central nervous system therapeutics

Exciva GmbH is engaged in central nervous system research with a focus on medicines intended to reduce disruptive symptoms arising in dementia.

  • CNS disorders
  • Dementia-related symptoms
  • Behavioral symptom treatment

The sponsor's work is aligned with therapeutic development for brain-related disorders where behavioral symptoms are a major clinical concern.

Geriatric medicine

The sponsor's clinical interest extends to older adults affected by Alzheimer's disease dementia, particularly those experiencing agitation that can complicate care and quality of life.

  • Age-related cognitive decline
  • Dementia care
  • Late-life behavioral symptoms

This domain reflects a focus on medical needs arising in geriatric populations with complex cognitive and behavioral symptoms.

Sponsored Trials

Trial Name Country Status
Phase 2/3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of EXV-802 and EXV-801 in Participants with Agitation in Alzheimer’s DiseaseCzechia CzechiaGermany GermanyItaly ItalyPoland PolandSlovakia SlovakiaSpain SpainNot Yet Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)

This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 38 sites collaborated multiple times

This sponsor has worked with 38 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Nervous System Diseases1 trial
    449 other sponsors

Partnered Research Centres

38 centres
location_city
assignment185
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone
Address
Via Del Vespro 129, 90127 Palermo
Learn morearrow_forward
location_city
assignment143
Azienda Ospedaliero-Universitaria Sant Andre
Address
Via Di Grottarossa 1035-1039, 00189 Rome
Learn morearrow_forward
location_city
assignment10
Brain-Soultherapy s.r.o.
Address
K Nemocnici 1904, 272 01 Kladno
Learn morearrow_forward
location_city
assignment29
Centrum Medyczne Hcp Sp. z o.o.
Address
Ul. 28 Czerwca 1956 R. 194, 61-485 Poznan
Learn morearrow_forward
location_city
assignment16
ClinHouse Centrum Medyczne
Address
Ul. Tarnopolska 77, 41-807 Zabrze
Learn morearrow_forward
location_city
assignment19
Complejo Asistencial De Zamora Hospital Provincial De Zamora
Address
Calle De Hernan Cortes 40, 49020 Zamora
Learn morearrow_forward
Page 1 of 7

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Exciva GmbH.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.